Home
>
US Stocks
>
Aligos Therapeutics Inc
Aligos Therapeutics Inc
ALGS

Aligos Therapeutics Inc

$160.13%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
15.82
Today Low/High
15.71 / 16.32
52 Week Low/High
$12.82 / $37.51
Market Cap
$641.69M

Company Details

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Organisation
Aligos Therapeutics Inc
Employees
80
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Aligos Therapeutics Inc share price today

Can Indians buy Aligos Therapeutics Inc shares?

How can I buy Aligos Therapeutics Inc shares from India?

Can Fractional shares of Aligos Therapeutics Inc be purchased?

What are the documents required to start investing in Aligos Therapeutics Inc stocks?

We are a SEBI registered investement advisor